ELV
$295.75
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
Intraday
Recent News
UNH Expands Doulas: Better Outcomes or Margin Play Ahead?
UnitedHealth Group rolls out nationwide doula coverage, targeting better maternal outcomes and lower costs through preventive, value-based care.
Mizuho Lowers PT on Elevance Health (ELV), Keeps a Buy Rating
Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Mizuho analyst Ann Hynes lowered the firm’s price target on Elevance Health, Inc. (NYSE:ELV) from $413 to $350 and maintained a Buy rating on the stock. The analyst noted that the reduced price target […]
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 3.8% over the past six months, almost identical to the S&P 500.
Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative
Elevance Health (NYSE:ELV) entered into new network participation agreements with Myomo. The agreements expand coverage for advanced orthotic devices to tens of millions of Elevance members. Coverage spans commercial, Medicare Advantage, and Medicaid plans, adding to Elevance's technology-enabled care offerings. For you as an investor, this move speaks directly to how Elevance Health is shaping its core health benefits business around technology-enabled, patient-centered care. The Myomo...
Centene Is the Worst S&P 500 Stock Today. What’s Ailing the Health Insurer.
Centene’s CEO says the company expects to see continued contraction in its Affordable Care Act marketplace.